The use of Metformin and Gonadotrophin Releasing Hormone Antagonist for the treatment of women with Polycystic Ovary Syndrome undergoing In-vitro Fertilisation-Embryo Transfer. - Metformin and GnRH Antagonist co-treatment in IVF for women with PCOS

eeds Teaching Hospitals NHS Trust0 个研究点开始时间: 2009年7月13日最近更新: 2015年8月4日

适应症

试验速览

暂无简介。

•Women who will be invited to take part in this study would be subject to following inclusion criteria: •Women with a known diagnosis of PCOS (as defined by the Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group, 2004) •Women must have a normal follicular stimulating hormone (FSH) •Women must be 20-39 years of age •Women must have a BMI = 35 •Pre-treatment inclusion criteria would include: oSerum testosterone < 5.0 nmol/l oNormal prolactin oNormal thyroid function tests oNormal renal, liver & haematological indices
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 0
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range 0

•Women who do not conform to the above criteria would be excluded from the study In addition to the above these specific exclusion criteria would apply: •Women on other oral-antidiabetic agents or blood-glucose lowering preparations. •Women taking phenprocoumon •Women taking antivirals such as didanosine, stavudine, tenofovir. •Women taking cimetidine •Women taking ketofen •Women who have radiological examinations using contrast media within the preceding 48 hours. •Women with renal or hepatic impairment •Women who have had a recent myocardial infarct •Women with known vitamin B12 deficiency

发起方

eeds Teaching Hospitals NHS Trust